Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
126.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.80 (0.634%)
Market Cap: £526.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Form 8.5 (EPT/RI) - James Halstead PLC

4 May 2018 17:09

RNS Number : 2386N
Panmure Gordon & Co. plc
04 May 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

James Halstead PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

James Halstead PLC

(d) Date dealing undertaken:

03 May 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p Ordinary

Purchase

 

1,962

390p

 

387p

 

5p Ordinary

Sales

47,942

390p

385p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

04 May 2018

Contact name:

Nick Entwisle

Telephone number:

020 7886 2850

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERUGUMUAUPRGQC
Date   Source Headline
1st Dec 20177:00 amRNSAGM Statement
20th Oct 20173:00 pmRNSAnnual Report & Accounts
2nd Oct 20177:00 amRNSBoard Changes
2nd Oct 20177:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
14th Sep 201712:42 pmRNSNotice of Preliminary Results
14th Sep 20177:00 amRNSNotice of Preliminary Results
1st Aug 201710:43 amRNSTotal Voting Rights
1st Aug 20177:00 amRNSPre-Close Trading Statement
31st Jul 20175:53 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:40 pmRNSTotal Voting Rights
3rd Jul 20175:37 pmRNSBlock listing Interim Review
23rd Jun 20174:12 pmRNSDirector/PDMR Shareholding
12th Jun 201712:54 pmRNSDirector/PDMR Shareholding
9th Jun 20175:37 pmRNSTotal Voting Rights
12th May 20175:29 pmRNSDirector/PDMR Shareholding
12th May 20173:59 pmRNSDirector/PDMR Shareholding
5th Apr 20172:36 pmRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSInterim Results
6th Mar 20177:00 amRNSNotice of Results
30th Jan 20177:00 amRNSPre Close Trading Statement
13th Dec 201611:13 amRNSResult of AGM
2nd Dec 20167:00 amRNSAGM Statement
1st Dec 20167:00 amRNSTotal Voting Rights
1st Nov 201612:24 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSAnnual Financial Report
3rd Oct 20167:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
21st Sep 20167:00 amRNSNotice of Preliminary Results
15th Aug 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Aug 20167:00 amRNSPre-Close Trading Statement
1st Jul 20163:41 pmRNSBlock listing Interim Review
31st Mar 20167:00 amRNSInterim Results
8th Mar 20167:00 amRNSNotice of Interim Results
1st Feb 20164:51 pmRNSTotal Voting Rights
1st Feb 20167:00 amRNSPre Close Trading Statement
3rd Dec 20155:20 pmRNSDirector/PDMR Shareholding
1st Dec 20152:45 pmRNSTotal Voting Rights
27th Nov 201512:00 pmRNSChairman's Statement to the Annual General Meeting
2nd Nov 201511:39 amRNSTotal Voting Rights
29th Oct 20154:44 pmRNSDirector/PDMR Shareholding
23rd Oct 20159:45 amRNSAnnual Financial Report & Notice of AGM
29th Sep 20157:00 amRNSFinal Results
18th Sep 20157:00 amRNSNotice of Preliminary Results
31st Jul 20157:00 amRNSTotal Voting Rights
29th Jul 20157:00 amRNSPre-Close Trading Statement
28th Jul 20156:00 pmRNSBlocklisting Interim Review
24th Jul 20155:00 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSChange of Adviser
3rd Jun 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSInterim Results
20th Mar 20154:31 pmRNSNotice of Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.